Abemaciclib is prescribed for:
- HR-positive, HER2-negative advanced breast cancer
- With endocrine therapy
- Monotherapy after progression on prior therapies
- High-risk early breast cancer (adjuvant)
- Oncology targeted therapy
Back to Medication Guide
Abemaciclib
Generic Name: Abemaciclib
Brand Names: Verzenio
Abemaciclib is a CDK4/6 inhibitor for advanced breast cancer that can be used as monotherapy.
OncologyCDK4/6 Inhibitor
What It's Used For
Side Effects
Common side effects:
- Diarrhea (very common)
- Neutropenia
- Fatigue
- Nausea
- Abdominal pain
Serious side effects:
- Severe diarrhea
- Interstitial lung disease
- Venous thromboembolism
Additional Information
What is Abemaciclib?
Abemaciclib is a CDK4/6 inhibitor with continuous dosing and diarrhea as its dose-limiting toxicity.
Continuous Dosing
Unlike palbociclib and ribociclib, given continuously without a week off.
Monotherapy Option
Only CDK4/6 inhibitor approved as monotherapy after prior treatment failure.
Learn more at MedlinePlus.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Ask Dr. Zimmer
Have questions about Abemaciclib? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.